4//SEC Filing
EYETECH PHARMACEUTICALS INC 4
Accession 0001293941-05-000056
CIK 0001115285operating
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:07 PM ET
Size
7.5 KB
Accession
0001293941-05-000056
Insider Transaction Report
Form 4
ADAMIS ANTHONY P
Chief Scientific Officer
Transactions
- Sale
Common Stock
2005-08-01$11.35/sh−5,325$60,439→ 109,965 total
Holdings
- 6,280(indirect: by Daughter)
Common Stock
Footnotes (3)
- [F1]Transaction effected pursuant to a 10b5-1 plan dated April 25, 2005.
- [F2]These shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's brother-in law is the trustee of the trust. The reporting person disclaims benefical ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for puposes of Section 16 or for any other purpose.
- [F3]These shares are held in a trust for the benefit of the reporting person's son. The reporting person's brother -in-law is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for Section 16 or for any other purpose.
Documents
Issuer
EYETECH PHARMACEUTICALS INC
CIK 0001115285
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001115285
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:07 PM ET
- Size
- 7.5 KB